(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -62.45%-692.41K | 39.96%-347.85K | 10.31%-1.48M | 27.74%-250.49K | 6.39%-226.86K | -2.52%-426.24K | 10.67%-579.41K | -3.32%-1.65M | 39.88%-346.64K | -18.03%-242.34K |
Net income from continuing operations | -127.73%-1.78M | -50.73%-829.4K | -437.04%-63.62M | -537.34%-61.53M | -501.03%-760.05K | 15.54%-782.43K | 51.73%-550.27K | -343.98%-11.85M | -1,100.67%-9.65M | 77.73%-126.46K |
Operating gains losses | 125.00%39.15K | 188.50%83.03K | 14.63%-373.73K | -3,322.40%-137.82K | 127.61%14.47K | 69.46%-156.56K | -176.30%-93.82K | 74.80%-437.8K | 101.18%4.28K | 91.81%-52.41K |
Depreciation and amortization | -2.18%27.6K | -2.22%27.59K | -6.87%112.89K | -2.46%28.25K | -2.50%28.22K | -2.51%28.22K | -17.94%28.21K | -12.24%121.22K | -16.38%28.96K | -16.32%28.94K |
Asset impairment expenditure | --33.02K | --62.59K | 757.69%63.82M | ---- | ---- | --0 | --0 | --7.44M | ---- | ---- |
Unrealized gains and losses of investment securities | -265.68%-65.52K | 13.02%-77.78K | -2,138.89%-132.9K | -33.47%-100.17K | -77.62%17.15K | -30.03%39.55K | -73.33%-89.42K | -81.78%6.52K | -67.29%-75.06K | 464.34%76.64K |
Remuneration paid in stock | --0 | --0 | -45.19%810.15K | -79.52%67.3K | --370.35K | -65.47%276.5K | -72.47%96K | -20.99%1.48M | --328.55K | --0 |
Deferred tax | ---- | ---- | -330.41%-3.09M | ---- | ---- | ---- | ---- | 326.94%1.34M | ---- | ---- |
Other non cashItems | 972.53%1.52M | 243.86%484.85K | 12.51%580.21K | 8.75%149.3K | 9.71%148.22K | 13.59%141.68K | 18.94%141K | 26.49%515.69K | 25.73%137.3K | 31.00%135.11K |
Change In working capital | -1,833.31%-464.41K | 11.15%-98.73K | 249.18%407.33K | 433.32%536.88K | 85.13%-45.22K | 119.27%26.79K | -35.90%-111.12K | -805.13%-273.04K | -43.30%100.67K | -2,464.78%-304.16K |
-Change in receivables | -13,118.31%-468.59K | 509.02%188.82K | -87.00%-194.17K | -3,410.43%-255.56K | 184.41%33.93K | -145.46%-3.55K | 148.33%31K | -636.05%-103.83K | -107.33%-7.28K | -204.73%-40.2K |
-Change in payables and accrued expense | -86.21%4.18K | -102.32%-287.55K | 455.48%601.5K | 634.10%792.44K | 70.01%-79.16K | 586.22%30.34K | -706.89%-142.13K | -974.36%-169.21K | 37.97%107.95K | -934.29%-263.96K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -62.45%-692.41K | 39.96%-347.85K | 10.31%-1.48M | 27.74%-250.49K | 6.39%-226.86K | -2.52%-426.24K | 10.67%-579.41K | -3.32%-1.65M | 39.88%-346.64K | -18.03%-242.34K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 90.63%-33.02K | 79.94%-63.91K | 53.65%-801.29K | 38.51%-142.8K | 102.24%12.3K | 34.76%-352.2K | 22.03%-318.58K | 38.15%-1.73M | 60.11%-232.24K | 29.29%-548.13K |
Net PPE purchase and sale | --0 | 79.94%-63.91K | 53.65%-801.29K | 38.51%-142.8K | 102.24%12.3K | --0 | 22.03%-318.58K | 38.15%-1.73M | 60.11%-232.24K | 29.29%-548.13K |
Net other investing changes | 90.63%-33.02K | ---- | ---- | ---- | ---- | 34.21%-352.2K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 90.63%-33.02K | 79.94%-63.91K | 53.65%-801.29K | 38.51%-142.8K | 102.24%12.3K | 34.76%-352.2K | 22.03%-318.58K | 38.15%-1.73M | 60.11%-232.24K | 29.29%-548.13K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -2.57%-32.98K | -2.63%-32.16K | 1.74%-127.8K | -2.63%-32.16K | -2.63%-32.16K | -2.63%-32.16K | 13.12%-31.33K | -101.08%-130.06K | 13.12%-31.33K | 13.12%-31.33K |
Net issuance payments of debt | -2.57%-32.98K | -2.63%-32.16K | 1.74%-127.8K | -2.63%-32.16K | -2.63%-32.16K | -2.63%-32.16K | 13.12%-31.33K | 9.84%-130.06K | 13.12%-31.33K | 13.12%-31.33K |
Net common stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -2.57%-32.98K | -2.63%-32.16K | 1.74%-127.8K | -2.63%-32.16K | -2.63%-32.16K | -2.63%-32.16K | 13.12%-31.33K | -101.08%-130.06K | 13.12%-31.33K | 13.12%-31.33K |
Net cash flow | ||||||||||
Beginning cash position | -33.63%3.8M | -36.23%4.25M | -34.53%6.66M | -35.73%4.67M | -39.21%4.92M | -36.89%5.73M | -34.53%6.66M | 301.25%10.17M | -36.05%7.27M | -34.66%8.09M |
Current changes in cash | 6.44%-758.41K | 52.23%-443.92K | 31.32%-2.41M | 30.28%-425.45K | 69.98%-246.72K | 17.87%-810.6K | 15.00%-929.33K | -146.00%-3.51M | 48.93%-610.21K | 19.16%-821.8K |
End cash Position | -38.11%3.04M | -33.63%3.8M | -36.23%4.25M | -36.23%4.25M | -35.73%4.67M | -39.21%4.92M | -36.89%5.73M | -34.53%6.66M | -34.53%6.66M | -36.05%7.27M |
Free cash from | -62.45%-692.41K | 54.15%-411.76K | 32.46%-2.28M | 32.06%-393.29K | 71.30%-226.86K | -1.41%-426.24K | 15.06%-898K | 23.05%-3.38M | 50.05%-578.88K | 19.38%-790.47K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.